The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
S1406: Randomized phase II study of irinotecan and cetuximab with or without vemurafenib in BRAF-mutant metastatic colorectal cancer (mCRC).
 
Scott Kopetz
Consulting or Advisory Role - Agendia; Amgen; Bayer; Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Merrimack; Roche; Sysmex
Research Funding - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Lilly; Merrimack; Pfizer; Roche; Sanofi
 
Shannon McDonough
No Relationships to Disclose
 
Van Karlyle Morris
No Relationships to Disclose
 
Heinz-Josef Lenz
No Relationships to Disclose
 
Anthony M. Magliocco
No Relationships to Disclose
 
Chloe Evelyn Atreya
Speakers' Bureau - Bayer
Research Funding - GlaxoSmithKline
 
Luis A. Diaz
No Relationships to Disclose
 
Carmen Joseph Allegra
No Relationships to Disclose
 
Christopher Hanyoung Lieu
No Relationships to Disclose
 
S. Gail Eckhardt
Stock and Other Ownership Interests - Entremed
Honoraria - Boehringer Ingelheim; Janssen Oncology; Kyowa Hakko Kirin; Lilly/ImClone
Consulting or Advisory Role - Onconova Therapeutics; Sanofi
Research Funding - AstraZeneca (Inst); Genentech (Inst); OncoMed (Inst); Pfizer (Inst); Rexahn Pharmaceuticals (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Boehringer Ingelheim; Genentech; Kyowa Hakko Kirin; Lilly/ImClone; Sanofi
 
Thomas John Semrad
Consulting or Advisory Role - Amgen; Celgene; Genentech; Genomic Health; Onyx
Research Funding - Astex Pharmaceuticals (Inst); Eisai (Inst); Genentech (Inst); Millennium (Inst); Morphotek (Inst); Novartis (Inst)
 
Kimberly Kaberle
No Relationships to Disclose
 
Katherine Guthrie
No Relationships to Disclose
 
Howard S. Hochster
No Relationships to Disclose